missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Human LXR alpha (aa 318-329) Synthetic Peptide

Numéro de catalogue. PEP114
Modifier l'affichage
Click to view available options
Quantité:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Numéro de catalogue. Quantité
PEP114 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Numéro de catalogue. PEP114 Fournisseur Invitrogen™ Code fournisseur PEP114
Saison des économies
Afficher toutes les promotions

Pour de l'aide SVP utiliser la function de clavardage; nous envoyer un couriel à help@thermofisher.com ou appelez le service à la clientèle au 1-800-234-7437.

Synthetic Peptide

PEP-114 is a 12 amino acid synthetic peptide whose sequence corresponds to residues 318-329 of human LXR alpha with an amino-terminal cysteine added for carrier protein conjugation. The sequence of this peptide is (amino to carboxy terminus): C-D318-F-S-Y-N-R-E-D-F-A-K-A (329). This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product and human LXR alpha, catalog # PA1-330. Using a solution of peptide of equal volume and concentration to the corresponding antibody will yield a large molar excess of peptide (~70-fold) for competitive inhibition of antibody-protein binding reactions. Reconstitute with 0.1 mL of distilled water.

NR1H3 (oxysterols receptor LXR-alpha) is a nuclear receptor that exhibits a ligand-dependent transcriptional activation activity. Its interaction with retinoic acid receptor (RXR) shifts RXR from its role as a silent DNA-binding partner to an active ligand-binding subunit in mediating retinoid responses through target genes defined by LXRES. LXRES are DR4-type response elements characterized by direct repeats of two similar hexanucleotide half-sites spaced by four nucleotides. NR1H3 plays an important role in the regulation of cholesterol homeostasis, regulating cholesterol uptake through MYLIP-dependent ubiquitination of LDLR, VLDLR, and LRP8. It also interplays functionally with RORA for the regulation of genes involves in liver metabolism.

Spécifications

ID du gène (Entrez) 10062
Espèces Human
Méthode de purification purified
Numéro d'enregistrement Q13133
Nom usuel LXR alpha
Concentration 0.5 mg/mL
Contenu et stockage -20°C. Avoid freeze-thaw cycles.
Aperçu général Synthetic Peptide
Format Lyophilized
Formule Peptide with no preservative
À utiliser avec (application) Control
Alias du gène AU018371; liver X nuclear receptor alpha variant 1; liver X receptor alpha; LXR; LXR alpha; Lxra; LXR-a; LXRalpha; LXRb; NER; NERI; NR1H2; Nr1h3; nuclear orphan receptor LXR-alpha; nuclear oxysterol receptor LxR-alpha; nuclear receptor subfamily 1 group H member 3; nuclear receptor subfamily 1, group H, member 3; oxysterols receptor LXR-alpha; RLD1; RLD-1; ubiquitously-expressed nuclear receptor 1; Unr1
Symbole de gène NR1H3
Lyophilisé Yes
Conservateur No preservative
Type de produit Peptide
Quantité 50 μg
Statut réglementaire RUO
Séquence C-D318-F-S-Y-N-R-E-D-F-A-K-A(329)
Afficher plus de résultats Afficher moins de résultats